Running Title: High CD105 levels promote vessel instability and metastasis
INTRODUCTION
Cancer is a generic term for a large group of diseases characterized by the growth of abnormal cells (tumor cells) beyond their usual boundaries, invading adjoining parts of the body and even spreading to other organs. Tumor tissue is highly proliferative, expansive and has high metabolic requirements; thus, the oxygen demand soon exceeds the input (1) . For this reason, as described in the 1970s, solid tumors cannot grow more than a few millimeters in the absence of the development of new blood vessels (2) . Angiogenesis is the main event through which these vessels are created.
Angiogenesis is the de novo formation of blood vessels from preexisting vessels in response to several stimuli, mainly hypoxia. The principal phases of this process include endothelial cell (EC) activation, tip and stalk cell differentiation, basement membrane degradation, EC sprouting and branching, vessel lumen formation, vessel anastomosis and mural cell recruitment, resulting in a new vascular network that provides blood to the hypoxic tissue (3) (4) (5) . Tumor angiogenesis is characterized by the dysregulation of many of these processes, leading to irregular and chaotic tumor neovessel formation and thus to dysfunctional and more permeable vessels that facilitate the circulation and homing of tumor cells in other tissues (1, 6) .
Endoglin (CD105) is an auxiliary receptor for several members of the TFG-β superfamily of cytokines. There is a substantial amount of evidence that relates endoglin to angiogenesis. On the one hand, endoglin expression is increased in the endothelium 3 during active angiogenesis (7) , specifically at the angiogenic edge, where sprouting takes place (8, 9) . On the other hand, deficiency in endoglin expression is responsible for hereditary hemorrhagic telangiectasia type-1 (HHT-1), a disease characterized by vascular malformations (10) . In experimental models, the lack of or deficiency in endoglin produces minor and defective angiogenesis (8, (11) (12) (13) .
Because angiogenesis is essential for the growth of tumors, the quantification of microvessel density is a frequent clinical practice to assess tumor prognosis (14) (15) (16) .
More specifically, a high number of endoglin-positive microvessels detected by immunohistochemistry has been associated with poor prognosis in some solid tumors (17, 18) . Moreover, enhanced endoglin expression in tumor microvessels is a better outcome predictor for some cancer types than the levels of other angiogenesis-related molecules (19, 20) . In addition, treatment with the anti-endoglin monoclonal antibody TRC105 or with different anti-endoglin shRNAs, siRNAs or miRNAs reduces tumor growth through the reduction of blood vessels inside the tumor (21) . All these observations have led to the assumption that the worse prognosis of tumors with high levels of endoglin is due to greater angiogenesis and, therefore, greater tumor growth, although this hypothesis has not been experimentally demonstrated. Recently, it has been shown that anti-endoglin therapy reduces the generation of metastases (22, 23) ; however, the exact mechanisms by which endoglin could contribute to the generation of metastases have not been reported.
Here, we demonstrate that continuous endoglin overexpression does not enhance tumor growth or vascularization. However, it produces alterations throughout the course of angiogenesis that prevent blood vessels from maturing and stabilizing, leading to even poorer quality tumor vessels and facilitating the intravasation and metastasis of tumor cells. For this purpose, we used transgenic mice overexpressing endoglin (ENG + ) in a C57BL/6J background, with C57BL/6J mice as controls (WT) (24) , and several in vitro approaches to study angiogenesis and the specific events that take place during blood vessel formation. 4 
MATERIALS AND METHODS
Mice. All animal procedures were European Community Council Directive (2010/63/EU) and Spanish legislation (RD1201/2005 and RD53/2013) compliant and approved by the University of Salamanca Ethical Committee. Animal selection was genotype based and no randomization or blinding was performed. Animals were housed under specific pathogen-free conditions in University of Salamanca facilities (ES-119-002001 SEARMG), in a temperature-controlled room with 12-hour light/dark cycle and reared on standard chow and water provided ad libitum. The generation and characteristics of the transgenic mice ubiquitously overexpressing endoglin (ENG + ) are described in a previous article from our group (24) . Wild-type C57BL/6J mice (WT) were used as controls. For animal anesthesia, 2% isoflurane in oxygen was used.
During recovery from the anesthesia, heat was provided and, when necessary, a dose of buprenorphine (0.05 mg/kg) was subcutaneously administered. Animals were sacrificed by CO2 inhalation or cervical dislocation, depending on the age and the experiment requirements. 
RESULTS

Constitutive endoglin overexpression increases the tortuousness of tumor vessels
Subcutaneous injection of Lewis lung carcinoma (LLC) cells in ENG + and WT mice
results in the generation of solid tumors in the flanks of the mice. Contrary to what we expected, the tumors that developed in ENG + mice did not grow larger than those in the WT mice; no significant differences were found between the weight of the tumors in the two mouse lines (Fig. 1a ). Moreover, immunohistochemistry of Pecam1 did not show differences in the number of vessels generated inside the tumors (Fig. 1b-c) .
Accordingly, the expression levels of murine endothelial markers such as endogenous endoglin (Eng) and Pecam1 were analyzed in tumors by qPCR, and no differences were found between ENG + and WT tumors ( Supplementary Fig. 1a ). However, hematoxylin/eosin staining showed that the vessels inside the tumors developed in ENG + mice were even more impaired and tortuous than those that developed in WT mice, resulting in increased blood extravasation, blood islets and tumor edema ( Fig.   1c-d ). This result was confirmed by measuring the hemoglobin concentration in the tumor tissue, which was higher in the tumors from ENG + than in those from WT mice ( Fig. 1e ). In summary, although dilated and tortuous vessels are characteristic of tumor vasculature, constitutive overexpression of endoglin enhances this characteristic, presumably by affecting the quality of angiogenesis.
Sustained endoglin overexpression does not improve post-ischemic reperfusion
To verify whether endoglin overexpression affects the angiogenesis rate, its effect on post-ischemic reperfusion was analyzed. Blood flow in the lower limbs of mice after femoral arterial ligation was measured periodically for 28 days. No significant differences in the reperfusion rates were detected between ENG + and WT mice throughout this period ( Fig. 1f-g) . Furthermore, the structure of the blood vessels was assessed in the soleus muscle after 14 days of ischemia by immunohistochemistry of Pecam1. No differences in vessel number were observed between ENG + and WT mice, but an increased Pecam1-positive area and dilated vessels observed in ENG + mice indicated the presence of alterations in the vessel structure in the reperfused muscle tissue ( Fig. 1h -j). 9 
Constitutive overexpression of endoglin leads to impaired physiological angiogenesis and an altered structure of the new blood vessels
The direct in vivo angiogenesis assay (DIVAA TM ) consists of the subcutaneous implantation of silicon tubes filled with Matrigel® plus proangiogenic factors into mice.
These tubes are invaded by vessels from the mice due to an angiogenic response. The measured distance reached by the red front in each tube was higher in the tubes implanted in ENG + mice than in those implanted in control mice ( Fig. 1k -l), which may suggest increased angiogenesis. However, constitutive endoglin overexpression led to a reduced EC content within the tubes 9 days after implantation ( Supplementary Fig.   1d ). qPCR analysis of the expression levels of a specific EC marker in the plugs of Matrigel® (analog to DIVAA TM ) showed no significant differences between ENG + and WT mice ( Supplementary Fig. 1c ). The fact that in ENG + mice, the vessels reach a longer distance with no increase in the number of ECs suggests that the red front observed in ENG + tubes was not the length invaded by blood-filled vessels but rather extravasated erythrocytes from the defective vessels that moved into the Matrigel®, as shown for the tumors.
Another frequently used method to study physiological angiogenesis is the analysis of the development of the retinal vasculature, which takes place between postnatal day 0 (P0) and P8 (25) . Retinas were isolated from P6 ENG + and WT pups, and the vessels were identified with FITC-isolectin B4. Structural analysis revealed that compared with WT retinas, ENG + retinas showed a lower degree of vascular plexus progression ( Fig.   1m -n) and a higher vessel density due to increased ramification ( Fig. 1m-o ). No differences in the expression levels of the EC markers Eng and Pecam1 were found between retinas from ENG + and WT mice ( Supplementary Fig. 1b ), suggesting that the lower degree of plexus progression is not due to a reduced number of ECs but rather to alterations in angiogenesis-driven vascularization.
The effect of endoglin overexpression was also evaluated using the in vitro angiogenesis assay. The human EC line EA.hy926 infected with a vector containing human endoglin gene (ENG + ) or with the empty vector (Mock) ( Supplementary Fig. 2ab , d-f) was used for this assay, in which the cells spontaneously organize to form capillary-like structures in Matrigel®. We found no differences in the number of 10 branches or in the average branch length in the structures created by Mock and ENG + cells ( Supplementary Fig. 2g-i) . Thus, it can be concluded that the alterations in angiogenesis observed in tumors and the physiological vascularization demonstrated in ENG + mice are not due to the inability of ECs to organize themselves into threedimensional structures.
An excess of endoglin in ECs reduces proliferation while promoting migration and extracellular matrix invasion
After demonstrating that continuous endoglin overexpression does not affect the ability of ECs to create three-dimensional structures, we studied whether high levels of endoglin alter any of the cellular processes involved in angiogenesis. EC proliferation and migration towards angiogenic stimuli are key highly regulated events during sprouting angiogenesis (26). The effects of endoglin overexpression on these cellular events were assessed in vitro using EA.hy926 ECs (ENG + and Mock) and mouse lung endothelial cells (MLECs) isolated from ENG + and WT mice ( Supplementary Fig. 2c-f ).
We studied bromodeoxyuridine (BrdU) incorporation in MLECs and EA.hy926 ECs as an assessment of cell proliferation. The level of BrdU incorporation was significantly lower in ENG + MLECs and ENG + EA.hy926 ECs than in WT and Mock cells, respectively ( Fig. 2ab ). A tendency to reduce proliferation in ENG + EA.hy926 ECs compared to Mock cells was also observed by direct cell counts (Fig. 2c ).
Cell motility was analyzed by the scratch assay in EA.hy926 EC monolayers in culture.
The results showed that the overexpression of endoglin in human ECs increased their motility in culture ( Fig. 2d-e ). Moreover, we analyzed the ability of EA.hy926 EC and MLEC to migrate towards the angiogenic stimulus VEGF using uncoated transwells and EC invasiveness through the extracellular matrix (ECM) using Matrigel®-coated transwells. Enhanced endoglin expression is associated with an increase in cell migration towards VEGF in both EA.hy926 ECs and MLECs (Fig. 2f) . Similarly, endoglin overexpression increases ECM invasion in ECs (Fig. 2g ).
Alterations in proliferation and migration caused by endoglin overexpression are not due to modifications in the tip/stalk selection during sprouting 11 The phenotype of a nonproliferative and highly migratory cell is typical of the so-called tip cells, which are responsible for sprout management during angiogenesis (26). The fact that overexpression of endoglin is associated with less proliferation and more migration and invasion could suggest that endoglin overexpression increases the number of tip cells. To study the first steps of sprouting, we performed an ex vivo aortic ring angiogenesis assay with samples from ENG + and WT mice; in this assay, sprouting from the ring endothelium is induced when it is cultured under proangiogenic conditions. No differences were found in the volume occupied by the sprouts around ENG + and WT rings on day 5 of the assay ( Supplementary Fig. 3a-b) .
Moreover, the expression levels of endothelial (Pecam1 and endogen Eng) and sprouting markers (Kdr, Notch1, Dll4 and Jag1) (26,27) in the sprout cells were not different between rings from the two mice lines ( Supplementary Fig. 3c-d ).
We also analyzed the expression of sprouting markers in retina and in plug assay models. Relativization of Kdr and Notch1 expression to the expression of EC markers (Eng/Pecam1) in these tissue samples corrects potential differences in EC content. This analysis revealed no differences in ENG + retinas when compared to WT retinas ( Supplementary Fig. 3e ). Furthermore, no differences were found between the two mouse lines regarding the expression levels of Kdr, Notch1, Dll4 and Jag1 in the plugs ( Supplementary Fig. 3f ).
These results suggest that, whereas ECs overexpressing endoglin may have a tip-like phenotype, increased levels of endoglin do not affect Notch-induced tip/stalk cell selection or the EC genetic profile.
Alterations in angiogenesis caused by continuous endoglin overexpression are due to overactive endothelium
We aimed to assess whether altered vascular architecture in mice with constitutive endoglin overexpression is due to an effect on endothelium stability. We analyzed the expression of VE-cadherin (Cdh5) in confluent and nonconfluent MLECs. These cells create stable unions when they are confluent, and Cdh5 gene expression levels directly affect these junctions (28, 29) . We observed an increase in Cdh5 expression in confluent WT MLECs compared to the level in nonconfluent cells. This increase was not 12 observed in ENG + MLECs (Fig. 3a ), suggesting a reduction in endothelium stabilization in vitro. We also analyzed the gene expression levels of Cdh5 and the angiopoietin receptor Tie2 (Tek), the levels of which are increased in the quiescent endothelium (30) , retinas and Matrigel® plugs. There was a decrease in the level of Tek expression in ENG + retinas compared to the level in WT retinas, although we found no differences in Cdh5 expression ( Supplementary Fig. 4a-b) .
However, the role of VE-cadherin in endothelium stabilization depends not only on its expression but also on its distribution along the cell membrane. After the first contacts between ECs, a punctuated pattern of VE-cadherin can be observed. These junctions are called discontinuous, irregular or active and characterize the response to stimuli that reduce the integrity of the endothelial barrier. Subsequently, these complexes create the continuous, regular or inactive adhesions that are present in quiescent vessels (31) . For this reason, we analyzed VE-cadherin distribution by immunofluorescence in the central area of the retinal vasculature because under physiological conditions, that should be a stabilized area (Fig. 3b) . The image quantification using the "patching algorithm" for MATLAB software (32) demonstrated that compared with WT retinas, ENG + retinas have a greater number of irregular junctions (Fig. 3b-d) . Moreover, immunofluorescence of the proliferation marker Ki67 showed that compared with WT retinas, the central area of the ENG + retinal vascular plexus contains more proliferating cells (Fig. 3e) . These results confirm that continuous endoglin overexpression prevents endothelium stabilization.
Continuous overexpression of endoglin inhibits pericyte recruitment to the newly formed capillaries
Endoglin has been reported to play a major role in vessel maturation (33, 34) .
Additionally, it has been shown that the RGD sequence of the extracellular domain of endoglin mediates pericyte binding to the ECs (35) . However, the greater activation of the endothelium caused by endoglin overexpression could impair mural cell attachment. Thus, we first studied in vitro mural cell recruitment in a coculture of EA.hy926 ECs and human brain vascular pericytes (HBVPs) in Matrigel®. As discussed above, ECs create capillary-like structures when cultured under these conditions. When cocultured with HBVPs, we observed that compared with Mock cells, ENG + 13 EA.hy926 ECs recruit fewer mural cells to these structures. Moreover, we studied the adhesion of HBVPs to a monolayer of ENG + or Mock EA.hy926 ECs, and we found reduced adhesion to ECs that overexpress endoglin (Fig. 4a-c) .
We also aimed to confirm whether endoglin overexpression decreases vessel maturation in vivo. We found no differences in the expression of Pdgfrb in retinas from WT and ENG + mice ( Supplementary Fig. 4c ), suggesting an equivalent number of mural cells in the retinas. To analyze the distribution of these mural cells, we performed colabeling of the retinal endothelium with FITC-isolectin B4 and NG2, which is a pericyte marker. There was almost complete colocalization in WT retinas, but we observed endothelium that was not entirely covered by mural cells and pericytes that did not appear to be bound to the endothelium in ENG + retinas, suggesting impaired mural cell attachment ( Fig. 4d-e ). Similarly, we analyzed the expression of mural cell markers in plugs of Matrigel®, and we observed the same results as in retinas. It seems that there are equal numbers of mural cells in plugs ( Supplementary Fig. 4d ). We then analyzed the vessel maturation state by quantifying the immunofluorescence of the endothelial marker Pecam1 and the mural marker NG2. This assay confirmed that vessels from ENG + plugs have less mural coverage than vessels from WT plugs ( Fig. 4df ).
Continuous endoglin overexpression produces leaky vessels that facilitate tumor cell intravasation and metastasis generation
The lower stability of the endothelium and the impaired vessel maturation can lead to an enhanced permeability of the vessels. Therefore, the evidence gathered so far may explain the increased infiltration of erythrocytes in the stroma of tumors developed in ENG + mice (Fig. 1c) . Interestingly, all the vessel structure alterations that we observed after tumor angiogenesis could have more serious consequences, such as the intravasation of tumor cells. For this reason, we analyzed the presence of metastases in WT and ENG + mice after tumor induction with LLC cells infected with green fluorescence protein (GFP). Mouse lungs were then analyzed to quantify the number of GFP-positive foci as evidence of the presence of tumor cells after metastasis. In agreement with the previous results, compared with WT lungs, ENG + lungs had more tumor loci ( Fig. 5a-b) . Moreover, compared with WT mice, ENG + mice had a higher 14 number of circulating GFP-LLC cells, as evidenced by the fact that blood from these mice generated more GFP + cell colonies in vitro (Fig. 5c ). These results suggest that continuous endoglin overexpression promotes tumor cell intravasation and the development of metastases in mice.
DISCUSSION
In this study, we demonstrated that high levels of endoglin do not improve angiogenesis; instead, constitutive endoglin overexpression produces alterations in the structure of the vasculature. These alterations do not seem to be due to defects during the first phases of angiogenesis; instead, endoglin overexpression prevents vessel stabilization and maturation, as shown in vitro and in vivo. In tumors, this instability leads to the extravasation of erythrocytes to the tumor stroma and the intravasation of malignant cells, without affecting the tumor size. All this may explain the mechanism, which has never been demonstrated before, by which high levels of endoglin in different solid tumors are associated with a worse prognosis (17, 18) and the mechanism by which anti-endoglin therapy reduces the generation of metastases (22, 23) .
Different authors have proposed that because endoglin deficiency impairs angiogenesis (8, 11, 13) , its pathological overexpression may enhance angiogenesis.
However, our results indicate that endoglin overexpression produces a pathological phenotype that affects mainly the stabilization and maturation phases of the angiogenic process. Thus, considering the results of previous studies and our results, we propose a model that could explain the consequences of endoglin levels being above or below physiological levels ( Fig. 6a ) and the importance of fine-tuned endoglin regulation during angiogenesis. According to this model, it is necessary for endoglin expression to increase during sprouting (8, 9) up to a threshold level, which may not be reached in Eng -/and Eng +/mice, in which the initial phases of angiogenesis do not occur correctly. This is supported by the results of numerous studies that have demonstrated that endoglin expression is increased in the angiogenic edge (8, 9) and that its deficiency can alter the proliferation of ECs (8, 36, 37) , migration of ECs (8, 11, 38) and three-dimensional organization of ECs in Matrigel® (8, 11) . These alterations may lead to impaired sprouting from Eng +/aortic rings (8) and finally to defects in vessel 15 formation in Eng +/animals (8, 11, 13) . On the other hand, our results suggest that physiological endoglin expression is enough to develop the initial phases of angiogenesis, as endoglin overexpression does not enhance these phases. In contrast, constitutive endoglin overexpression alters endothelium stabilization and mural cell recruitment, as demonstrated in this study both in vitro and in vivo. Thus, during the final phases, it seems necessary for endoglin levels to decrease to basal levels to allow the maturation of the vessels, as sustained endoglin overexpression maintains the activation of ECs. Some authors have shown that endoglin-deficient vessels also present altered stabilization and maturation (35, 39) , giving rise to more permeable vessels (35, 40, 41) . However, this phenotype seems to be explained by the lack of direct interaction between endothelial endoglin and the integrins of pericytes (35) .
Regarding cancer development, other authors have shown that endoglin deficiency or different anti-endoglin treatments reduce the vascularity of tumors and, therefore, decrease tumor growth (21, (42) (43) (44) (45) . However, according to our model and our results, the poor prognosis associated with high levels of endoglin is not related to a greater number of vessels or a larger tumor size. Instead, we propose a second model (Fig. 6b) in which the lack of downregulation of endoglin levels in the tumor endothelium after angiogenesis leads to the lack of stabilization and increased impairment of the function of tumor vessels. This could result in an inadequate nourishment of the tumor, limiting its growth but also increasing hypoxia, which causes tumor cells to acquire a more aggressive phenotype (46, 47) . In addition, the intravasation of malignant cells could be facilitated by increased vessel instability and impaired mural coverage (48) . Accordingly, our results show increased tumor cell intravasation in ENG + mice compared with WT mice. Considering that metastases are responsible for 90% of cancer deaths, we propose the following new hypothesis: the worse prognosis of patients with tumors with high levels of endoglin is not due to increased tumor size; instead, the overexpression of endoglin maintains the activation of the endothelium and increases the risk of metastases. This hypothesis is in accordance with previous observations of increased metastases in tumors with high levels of endoglin staining (49) . 16 As stated previously, some studies have shown that the administration of anti-endoglin antibodies, such as TRC105, decreases the number of metastases (22, 23) , although an explanation of the mechanisms by which endoglin contributes to metastasis generation has been lacking. Considering our model (Fig 6b) , we hypothesize that antiendoglin therapies are not only antiangiogenic, as described above (21, 50) , but also reduce the generation of metastases by promoting the stabilization of the endothelium and the normalization of vessels. One limitation of our study is that endoglin overexpression is ubiquitous, which means that endoglin levels are above the physiological level in all cell types other than ECs, including those in the tumor microenvironment, which may also play an important role in the malignancy of tumors. For example, beyond its antiangiogenic effect on the endothelium, antiendoglin treatment inhibits cancer-associated fibroblast (CAF) invasion and metastasis (51) . However, our in vitro results show that endoglin overexpression results in a permanent activation of the endothelium that prevents the maturation of the vessels. Therefore, although it may not be the only cell type involved, we can conclude that the persistence of active endothelium is one of the main causes of the intravasation of tumor cells and the generation of metastases.
Moreover, several studies have shown that the low functionality of tumor vessels prevents conventional anti-tumor therapies from reaching the entire tumor, reducing their effectiveness (46) . This is also likely to occur in tumors with high levels of endoglin and may also be related to a worse prognosis (Fig. 6b ).
In summary, we demonstrate that, although an increase in endoglin expression is necessary during the first phases of angiogenesis, endoglin expression must return to basal levels to allow mural cell recruitment. This is a key event in tumors, in which the proangiogenic stimuli are very potent and vessel instability facilitates the intravasation of malignant cells and hampers anti-tumor therapy efficacy. Therefore, the normalization of the vasculature resulting from the administration of anti-endoglin therapies may reduce tumor cell intravasation and increase the effectiveness of chemotherapy, as has already been observed with anti-VEGF and ALK1-Fc treatments (46, 52, 53) . 
